210 related articles for article (PubMed ID: 37284308)
21. Nine-gene pharmacogenomics profile service: The Mayo Clinic experience.
Matey ET; Ragan AK; Oyen LJ; Vitek CR; Aoudia SL; Ragab AK; Fee-Schroeder KC; Black JL; Moyer AM; Nicholson WT; Shrestha S; McAllister TM; Sinnwell JP; Faubion SS; Lazaridis KN
Pharmacogenomics J; 2022 Feb; 22(1):69-74. PubMed ID: 34671112
[TBL] [Abstract][Full Text] [Related]
22. An updated examination of the perception of barriers for pharmacogenomics implementation and the usefulness of drug/gene pairs in Latin America and the Caribbean.
Salas-Hernández A; Galleguillos M; Carrasco M; López-Cortés A; Redal MA; Fonseca-Mendoza D; Esperón P; González-Martínez F; Lares-Asseff I; Lazarowski A; Loera-Castañeda V; Remírez D; Martínez MF; Vargas R; Rios-Santos F; Macho A; Cayún JP; Perez GR; Gutierrez C; Cerpa LC; Leiva T; Calfunao S; Xajil L; Sandoval C; Suárez M; Gonzalez A; Echeverría-Garcés G; Sullón-Dextre L; Cordero-García E; Morales AR; Avendaño A; Sánchez E; Bastone LC; Lara C; Zuluaga-Arias P; Soler AM; Da Luz J; Burgueño-Rodríguez G; Vital M; Reyes-Reyes E; Huaccha A; Ariza YV; Tzul N; Rendón AL; Serrano R; Acosta L; Motta-Pardo A; Beltrán-Angarita L; Brand E; Jiménez MA; Hidalgo-Lozada GM; Romero-Prado MMJ; Escobar-Castro K; Umaña-Rivas M; Vivas JD; Lagos P; Martínez YB; Quesada S; Calfio C; Arias ML; Lavanderos MA; Cáceres DD; Salazar-Granara A; Varela NM; Quiñones LA
Front Pharmacol; 2023; 14():1175737. PubMed ID: 37251329
[TBL] [Abstract][Full Text] [Related]
23. Description of Pharmacogenomic Testing Among Patients Admitted to the Intensive Care Unit After Cardiovascular Surgery.
Peterson PE; Nicholson WT; Moyer AM; Arendt CJ; Smischney NJ; Seelhammer TG; Krecke CA; Haney RM; Yaw EJ; Chlan LL
J Intensive Care Med; 2021 Nov; 36(11):1281-1285. PubMed ID: 32734840
[TBL] [Abstract][Full Text] [Related]
24. Retrospective Review of Pharmacogenetic Testing at an Academic Children's Hospital.
Roberts TA; Wagner JA; Sandritter T; Black BT; Gaedigk A; Stancil SL
Clin Transl Sci; 2021 Jan; 14(1):412-421. PubMed ID: 33048453
[TBL] [Abstract][Full Text] [Related]
25. Use of Pharmacogenetic Drugs by the Dutch Population.
Alshabeeb MA; Deneer VHM; Khan A; Asselbergs FW
Front Genet; 2019; 10():567. PubMed ID: 31312209
[TBL] [Abstract][Full Text] [Related]
26. Genetic Variation among Pharmacogenes in the Sardinian Population.
Idda ML; Zoledziewska M; Urru SAM; McInnes G; Bilotta A; Nuvoli V; Lodde V; Orrù S; Schlessinger D; Cucca F; Floris M
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077453
[TBL] [Abstract][Full Text] [Related]
27. Added Value of Clinical Sequencing: WGS-Based Profiling of Pharmacogenes.
Caspar SM; Schneider T; Meienberg J; Matyas G
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225115
[TBL] [Abstract][Full Text] [Related]
28. Computational pharmacogenotype extraction from clinical next-generation sequencing.
Shugg T; Ly RC; Osei W; Rowe EJ; Granfield CA; Lynnes TC; Medeiros EB; Hodge JC; Breman AM; Schneider BP; Sahinalp SC; Numanagić I; Salisbury BA; Bray SM; Ratcliff R; Skaar TC
Front Oncol; 2023; 13():1199741. PubMed ID: 37469403
[TBL] [Abstract][Full Text] [Related]
29. Overcoming Barriers to Discovery and Implementation of Equitable Pharmacogenomic Testing in Oncology.
Shriver SP; Adams D; McKelvey BA; McCune JS; Miles D; Pratt VM; Ashcraft K; McLeod HL; Williams H; Fleury ME
J Clin Oncol; 2024 Apr; 42(10):1181-1192. PubMed ID: 38386947
[TBL] [Abstract][Full Text] [Related]
30. The genomic landscape of blood groups in Indigenous Australians in remote communities.
Jadhao S; Hoy W; Lee S; Patel HR; McMorran BJ; Flower RL; Nagaraj SH
Transfusion; 2022 May; 62(5):1110-1120. PubMed ID: 35403234
[TBL] [Abstract][Full Text] [Related]
31. A retrospective analysis of preemptive pharmacogenomic testing in 22,918 individuals from China.
Huang Q; Liao Y; Yu T; Lei W; Liang H; Wen J; Liu Q; Chen Y; Huang K; Jing L; Huang X; Liu Y; Yu X; Su K; Liu T; Yang L; Huang M
J Clin Lab Anal; 2023 Mar; 37(5):e24855. PubMed ID: 36916827
[TBL] [Abstract][Full Text] [Related]
32. The Gene-Drug Duality: Exploring the Pharmacogenomics of Indigenous Populations.
Nagaraj SH; Toombs M
Front Genet; 2021; 12():687116. PubMed ID: 34616423
[TBL] [Abstract][Full Text] [Related]
33. A comprehensive Thai pharmacogenomics database (TPGxD-1): Phenotype prediction and variants identification in 942 whole-genome sequencing data.
John S; Klumsathian S; Own-Eium P; Eu-Ahsunthornwattana J; Sura T; Dejsuphong D; Sritara P; Vathesatogkit P; Thongchompoo N; Thabthimthong W; Teerakulkittipong N; Chantratita W; Sukasem C
Clin Transl Sci; 2024 Jun; 17(6):e13830. PubMed ID: 38853370
[TBL] [Abstract][Full Text] [Related]
34. Potential Utility of Pre-Emptive Germline Pharmacogenetics in Breast Cancer.
Bernard PS; Wooderchak-Donahue W; Wei M; Bray SM; Wood KC; Parikh B; McMillin GA
Cancers (Basel); 2021 Mar; 13(6):. PubMed ID: 33799547
[TBL] [Abstract][Full Text] [Related]
35. Novel genetic markers for chronic kidney disease in a geographically isolated population of Indigenous Australians: Individual and multiple phenotype genome-wide association study.
Arunachalam V; Lea R; Hoy W; Lee S; Mott S; Savige J; Mathews JD; McMorran BJ; Nagaraj SH
Genome Med; 2024 Feb; 16(1):29. PubMed ID: 38347632
[TBL] [Abstract][Full Text] [Related]
36. Profiling of pharmacogenomic variants in
Alsulaiman A; Chu H; Al-Jumaan M; Alyahya M; Marzooq YA; Almulhim F; Vatte C; Alnimer A; Almuhanna A; Al-Ali A; AlDubayan SH
Pharmacogenomics; 2023 May; 24(7):411-423. PubMed ID: 37222147
[No Abstract] [Full Text] [Related]
37. Potentially actionable pharmacogenetic variants and symptom control medications in oncology.
Patel JN; Boselli D; Jandrisevits EJ; Hamadeh IS; Salem A; Meadors P; Walsh D
Support Care Cancer; 2021 Oct; 29(10):5927-5934. PubMed ID: 33758969
[TBL] [Abstract][Full Text] [Related]
38. Clinical implementation of preemptive pharmacogenomics in psychiatry: Τhe "PREPARE" study.
Tsermpini EE; Skokou M; Ferentinos P; Georgila E; Gourzis P; Assimakopoulos K; Patrinos GP;
Psychiatriki; 2020; 31(4):341-351. PubMed ID: 33361064
[TBL] [Abstract][Full Text] [Related]
39. Primary Care Prescription Drug Use and Related Actionable Drug-Gene Interactions in the Danish Population.
Lunenburg CATC; Hauser AS; Ishtiak-Ahmed K; Gasse C
Clin Transl Sci; 2020 Jul; 13(4):798-806. PubMed ID: 32166845
[TBL] [Abstract][Full Text] [Related]
40. Identification of high-impact gene-drug pairs for pharmacogenetic testing in Alberta, Canada.
Fan M; Yarema MC; Box A; Hume S; Aitchison KJ; Bousman CA
Pharmacogenet Genomics; 2021 Feb; 31(2):29-39. PubMed ID: 32826605
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
